Drug
Tegafur-uracil clinical trials
Also written UFUR and UFT.
- studies test it
- 25
- open now
- 0
- in phase 3
- 8
- first study started
- 1996
How studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 1996 (3)
| Year | Studies |
|---|---|
| 1996 | 3 |
| 1997 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 15
- Phase 3
- 8
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 21
National Taiwan University Hospital (4) · Taiho Pharmaceutical Co., Ltd. (4) · Chang Gung Memorial Hospital (2) · Fudan University (1) · Haruhiko Fukuda (1) · The Christie NHS Foundation Trust (1) · Taipei Veterans General Hospital, Taiwan (1) · Institut Cancerologie de l'Ouest (1)
Often tested with
Tested in the same studies.
Leucovorin (2) · Thalidomide (2) · Sorafenib (2) · Cetuximab (1) · Irinotecan (1) · Oxaliplatin (1) · Tamoxifen (1) · Gefitinib (1)
Studies
Open first, then newest update. How each study uses Tegafur-uracil is read from its arms, and is right about nine times in ten.
Testing it · 25
- Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal AdenocarcinomaTerminatedPhase 3Institut Cancerologie de l'OuestNCT00207831Written as Tegafur and Uracil
- Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+Status unknownPhase 2Chang Gung Memorial HospitalNCT03121313Written as tegafur-uracil
- Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical ResectionStatus unknownNot applicableKaohsiung Medical University Chung-Ho Memorial HospitalNCT02836977Written as tegafur-uracil
- Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrenceCompletedPhase 2Chang Gung Memorial HospitalNCT02447679Written as tegafur-uracil
- The Maintenance Treatment of UFT in Advanced Gastric CancerCompletedPhase 2Fudan UniversityNCT02903498Written as UFT
- A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)CompletedPhase 3Haruhiko FukudaNCT00190515Written as UFT+Leucovorin
- A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon CancerStatus unknownPhase 4National Taiwan University HospitalNCT02887365Written as tegafur-uracil
- Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACETerminatedPhase 2Egyptian Society of Liver CancerNCT01539018Written as sorafenib plus tegafur-uracil
- Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerTerminatedPhase 2Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanNCT01262274Written as Anastrozole plus tegafur-uracil
- Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedPhase 2The Christie NHS Foundation TrustNCT01225744Written as UFT
- S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck CancerStatus unknownPhase 3Yokohama City UniversityNCT00336947Written as tegafur-uracil
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedPhase 2National Taiwan University HospitalNCT00519688Written as Tegafur/Uracil
- Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaStatus unknownPhase 2Mackay Memorial HospitalNCT00855881Written as tegafur-uracil
- A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00152191Written as UFT (uracil, tegafur)
- A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00152230Written as UFT (uracil, tegafur)
- A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00152243Written as UFT (uracil, tegafur)
- The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00152178Written as UFT (uracil, tegafur) and tamoxifen
- UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedPhase 2Taipei Veterans General Hospital, TaiwanNCT01037998Written as UFUR and Iressa
- Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedPhase 2National Taiwan University HospitalNCT00464919Written as tegafur/uracil (UFUR®)
- Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerStatus unknownPhase 2National Cheng-Kung University HospitalNCT00890188Written as THALIDOMIDE and UFUR
See all 25 studies that test Tegafur-uracil →
Given in every arm · 2 — Tegafur-uracil is usual care beside what is tested
- A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal CancerStatus unknownPhase 3Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment GroupNCT00385970Written as Tegafur-uracil (UFT)
- Randomized Phase III Adjuvant Study for Stage III Colorectal CancerStatus unknownPhase 3Hokkaido Gastrointestinal Cancer Study GroupNCT00209742Written as UFT
As the comparator · 3 — what is tested is compared with Tegafur-uracil
- A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesActive, not recruitingPhase 3AstraZenecaNCT06564844Written as UFT
- Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by SurgeryCompletedPhase 3Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanNCT00660894Written as tegafur-uracil
- Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal CancerStatus unknownPhase 3Iwate Medical UniversityNCT00497107Written as UFT, Calcium Folinate
Codes
What other systems call Tegafur-uracil · ClinicalTrials.gg INT016786
- UNII (FDA) HMI5GR78FRTEGAFUR-URACILConfirmed FDA, Wikidata
- Wikidata Q27098002Tegafur-uracilConfirmed FDA, Wikidata
- NCI Thesaurus C9506Tegafur-UracilOne source FDA
- DrugBank DB09327One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | HMI5GR78FR | TEGAFUR-URACIL | Confirmed FDA, Wikidata |
| Wikidata | Q27098002 | Tegafur-uracil | Confirmed FDA, Wikidata |
| NCI Thesaurus | C9506 | Tegafur-Uracil | One source FDA |
| DrugBank | DB09327 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.